...
首页> 外文期刊>Mediators of inflammation >The Effect of Anti-Inflammatory and Antimicrobial Herbal Remedy PADMA 28 on Immunological Angiogenesis and Granulocytes Activity in Mice
【24h】

The Effect of Anti-Inflammatory and Antimicrobial Herbal Remedy PADMA 28 on Immunological Angiogenesis and Granulocytes Activity in Mice

机译:抗炎抗菌药草PADMA 28对小鼠免疫血管生成和粒细胞活性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

PADMA 28 is a herbal multicompound remedy that originates from traditional Tibetan medicine and possesses anti-inflammatory, antioxidant, antimicrobial, angioprotecting, and wound healing properties. The aim of the present study was to evaluate the influence of this remedy on immunological angiogenesis and granulocytes metabolic activity in Balb/c mice. Mice were fed daily, for seven days, with 5.8 mg of PADMA (calculated from recommended human daily dose) or 0.085 mg (dose in the range of active doses of other herbal extracts studied by us previously). Results. Highly significant increase of newly formed blood vessels number in ex vivo cutaneous lymphocyte-induced angiogenesis test (LIA) after grafting of Balb/c splenocytes from both dosage groups to Fl hybrids (Balb/c x C3H); increase of blood lymphocytes and granulocytes number only in mice fed with lower dose of remedy; and significant suppression of metabolic activity (chemiluminescence test) of blood granulocytes in mice fed with higher dose of PADMA. Conclusion. PADMA 28 behaves as a good stimulator of physiological angiogenesis, but for this purpose it should be used in substantially lower doses than recommended by producers for avoiding the deterioration of granulocyte function.
机译:PADMA 28是源自传统藏药的草药多元化合物,具有抗炎,抗氧化,抗菌,血管保护和伤口愈合的特性。本研究的目的是评估该疗法对Balb / c小鼠免疫血管生成和粒细胞代谢活性的影响。每天给小鼠喂食5.8 mg PADMA(根据建议的人类日剂量计算)或0.085 mg(在我们之前研究的其他草药提取物的有效剂量范围内),持续7天。结果。将来自两个剂量组的Balb / c脾细胞移植到F1杂种后,离体皮肤淋巴细胞诱导的血管生成测试(LIA)中新形成血管的数量显着增加(Balb / c x C3H);仅在以较低剂量的药物喂养的小鼠中,血液淋巴细胞和粒细胞数目增加;和高剂量PADMA喂养的小鼠的血粒细胞代谢活性(化学发光测试)得到显着抑制。结论。 PADMA 28可以很好地刺激生理性血管生成,但是为此目的,PADMA 28的剂量应比生产者推荐的剂量低得多,以避免粒细胞功能的恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号